Phase 1 Advanced Pancreatic Cancer Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Advanced Pancreatic Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.72 enrolled16 locationsNCT06821503
Recruiting
Phase 1Phase 2
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
Locally Advanced Pancreatic Cancer
University of Maryland, Baltimore24 enrolled2 locationsNCT03652428
Recruiting
Phase 1
A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer
Advanced Pancreatic Cancers
Tianjin Medical University Cancer Institute and Hospital21 enrolled1 locationNCT06760364
Recruiting
Phase 1Phase 2
Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV
Advanced Pancreatic Cancer (Part 1)
Dai, Guanghai138 enrolled2 locationsNCT06782685
Recruiting
Phase 1Phase 2
mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer
Metastatic Pancreatic CancerLocally Advanced Pancreatic Cancer
Fujian Provincial Hospital29 enrolled4 locationsNCT06761027